Info
Insider Trading

Insider Transactions Reported by 11 Insiders of Strongbridge Biopharma plc

Location: Trevose, PA

There are no Buy or Sell transactions made by insiders since 18 Mar 2025

Strongbridge Biopharma plc executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Fredric J. Cohen	Chief Medical Officer	$330,440			05 Oct 2021
David N. Gill	Director				05 Oct 2021
Jeffrey W. Sherman	Director				05 Oct 2021
CDK ASSOCIATES, L.L.C.	10%+ Owner				05 Oct 2021
Richard S. Kollender	President and CFO				05 Oct 2021
Stephen J. Long	Chief Legal Officer				05 Oct 2021
Marten Steen	Director				05 Oct 2021
Scott L. Wilhoit	Chief Commercial Officer				05 Oct 2021
John Johnson	Chief Executive Officer, Director				05 Oct 2021
Garheng Kong	Director				05 Oct 2021
Hilde H. Steineger	Director				05 Oct 2021

Recent Insider Transactions by Companies or Individuals for Strongbridge Biopharma plc

Showing up to 300 most recent insider transactions from the last 12 months.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership
No insider transactions were found in the last 12 months for this issuer.

* An asterisk sign (*) next to the price indicates that the price is likely invalid.